Strategy | Financing Transactions Private Placement / Financing Transactions City Therapeutics: The company raised $135 million of Series A venture funding in a deal led by ARCH Venture Partners on October 8, 2024. Regeneron Ventures, The Invus Group, AN Ventures,...
Strategy | Financing Transactions Private Placement / Financing Transactions Aktis Oncology: The company raised $175 million of Series B venture funding in a deal led by RA Capital Management, RTW Investments and Janus Henderson Investors on September 30, 2024. MRL...
trategy | Financing Transactions Private Placement / Financing Transactions EGYM: The company raised an estimated $200 million of Series G venture funding led by L Catterton with participation from Meritech Capital Partners on September 24, 2024, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Nura Bio: The company raised $141 million of Series A venture funding in a deal led by The Column Group on September 17, 2024, putting the company’s pre-money valuation at $35 million....
Strategy | Financing Transactions Private Placement / Financing Transactions Pantera: The company raised EUR 134 million of Series A venture funding on September 11, 2024, putting the company’s pre-money valuation at EUR 179.8 million. The company is an operator...
Strategy | Financing Transactions Private Placement / Financing Transactions Egenesis: The company raised $191 million of Series D venture funding in a deal led by Lux Capital on September 4, 2024. Fresenius Medical Care Ventures, Leaps by Bayer, DaVita, Eisai...
